Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Tew

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Biochemistry|January 28, 1997
Interaction of estramustine with tubulin isotypesN Laing, B Dahllöf, B Hartley-Asp, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporterS Paul, L M Breuninger, K D Tew, et al.
Biochemical Pharmacology|August 15, 1984
Biochemical and cytotoxic properties of the isomeric forms of N,N'-bis[N-2-chloroethyl)-N-nitrosocarbamoyl] cystamineJ J Farhi, M Bennoun, H Tapiero, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1998
ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporterS Paul, L M Breuninger, K D Tew, et al.
Cancer Research|April 1, 1979
Nitrosourea interaction with chromatin and effect on poly(adenosine diphosphate ribose) polymerase activityS Sudhakar, K D Tew, P S Schein, et al.
Biochemical Pharmacology|April 1, 1985
Mechanism of action of 2-haloethylnitrosoureas on deoxyribonucleic acid. Pathways of aqueous decomposition and pharmacological characteristics of new anticancer disulfide-linked nitrosoureasJ W Lown, R R Koganty, K D Tew, et al.
Molecular Pharmacology|October 1, 1995
Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitorsP J Ciaccio, H Shen, A K Jaiswal, et al.
Pharmacology & Therapeutics|December 1, 1992
Preclinical and clinical perspectives on the use of estramustine as an antimitotic drugK D Tew, J P Glusker, B Hartley-Asp, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Glutathione peptidomimetic drug modulator of multidrug resistance-associated proteinM L O'Brien, B Vulevic, S Freer, et al.
Cancer|May 15, 1995
Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteinsC D Smith, J T Zilfou, X Zhang, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Biochemistry|January 28, 1997
Interaction of estramustine with tubulin isotypesN Laing, B Dahllöf, B Hartley-Asp, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporterS Paul, L M Breuninger, K D Tew, et al.
Biochemical Pharmacology|August 15, 1984
Biochemical and cytotoxic properties of the isomeric forms of N,N'-bis[N-2-chloroethyl)-N-nitrosocarbamoyl] cystamineJ J Farhi, M Bennoun, H Tapiero, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1998
ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporterS Paul, L M Breuninger, K D Tew, et al.
Cancer Research|April 1, 1979
Nitrosourea interaction with chromatin and effect on poly(adenosine diphosphate ribose) polymerase activityS Sudhakar, K D Tew, P S Schein, et al.
Biochemical Pharmacology|April 1, 1985
Mechanism of action of 2-haloethylnitrosoureas on deoxyribonucleic acid. Pathways of aqueous decomposition and pharmacological characteristics of new anticancer disulfide-linked nitrosoureasJ W Lown, R R Koganty, K D Tew, et al.
Molecular Pharmacology|October 1, 1995
Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitorsP J Ciaccio, H Shen, A K Jaiswal, et al.
Pharmacology & Therapeutics|December 1, 1992
Preclinical and clinical perspectives on the use of estramustine as an antimitotic drugK D Tew, J P Glusker, B Hartley-Asp, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
Glutathione peptidomimetic drug modulator of multidrug resistance-associated proteinM L O'Brien, B Vulevic, S Freer, et al.
Cancer|May 15, 1995
Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteinsC D Smith, J T Zilfou, X Zhang, et al.
Pageof 15